Picture of Bioiasis AD logo

BIOA Bioiasis AD Income Statement

0.000.00%
bg flag iconLast trade - 00:00
HealthcareMicro Cap

Annual income statement for Bioiasis AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0.1750.1020.00100
Cost of Revenue
Gross Profit0.1370.065-0.033-0.039-0.029
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses0.1170.0960.0610.0750.075
Operating Profit0.0580.006-0.06-0.075-0.075
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes0.0550.0040.607-0.066-0.08
Provision for Income Taxes
Net Income After Taxes0.051-0.0250.535-0.05-0.078
Net Income Before Extraordinary Items
Net Income0.051-0.0250.535-0.05-0.078
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income0.051-0.0250.535-0.05-0.078
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.073-0.0060.457-0.04-0.064
Dividends per Share

Or unlock with your email

Or unlock with your email